每经记者 涂颖浩 每经编辑 张益铭 随着国家持续推进药品集中带量采购与DRG/DIP医保支付改革纵深落地,原研药及创新药临床应用可及性问题持续引发社会热议。在此背景下,商业健康保险作为多层次医疗保障体系的关键支柱,其补充价值与资源整合功能被赋予更高期待。 由中再寿险、镁信健康及波士顿咨询公司联合编写的《中国创新药械多元支付白皮书(2025)》(以下简称报告)显示,商业健康险对于...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.